Safety and Efficacy of Campath in Nonmyeloablative Transplantation

NCT00038844 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Leukemia

Interventions

DRUG: Campath-1 H (Alemtuzumab)
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center